Trade OSTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
OS Therapies Incorporated (OSTX) is trading at US$1.74, down 1.69% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$73.34M. Over the past 52 weeks, OSTX has traded between US$1.15 and US$2.25. On Syfe you can trade OSTX with $0 commission and add it to your watchlist.
| Previous close | US$1.77 |
|---|---|
| Market cap | US$73.34M |
| 52-week range | US$1.15 – US$2.25 |
| Volume | 635.97K |
| Exchange | US |
Add to Watchlist
Set Price Alert
OS Therapies Incorporated
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Grasonville, MD.
Year: 2024
--Roth Capital Initiates Coverage on OS Therapies With Buy Rating, $7 Price Target
Jul 9, 12:30 PM · MT Newswires
OS Therapies Advances Cancer Candidate in Europe, Australia
Apr 30, 3:07 PM · MT Newswires
OS Therapies Incorporated (OSTX) stock is trading at US$1.74, -1.69% from the previous close of US$1.77.
The market cap for OS Therapies Incorporated (OSTX) stock is approximately US$73.34M.
The 52-week high for OS Therapies Incorporated (OSTX) stock is US$2.25.
The 52-week low for OS Therapies Incorporated (OSTX) stock is US$1.15.
OS Therapies Incorporated (OSTX) does not currently pay a dividend.
Stay on top of OSTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
